RxDoctor Payments Data

Travis Charles, DO

Family Medicine · Salem, UTNPI 1255643136

Payments from drug & device makers

$7,745in general payments, 2019–2025

Across 616 payments — averaging $12.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Novo Nordisk$798
  • Lilly USA, LLC$592
  • Amgen$490
  • Astellas Pharma US Inc$476
  • AstraZeneca$383
  • plus $3K from 44 others

What the payments were for

  • Food & beverage$7,745100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$7,745 in reported general payments places this provider in the 85th percentile of 928 family medicine providers in Utah.

See all family medicine providers in Utah

Medicare billing

Part B allowed, 2024
$59,684
Medicare patients
158
Services billed
3,447

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide73$96,783
EliquisApixaban98$73,680
TrulicityDulaglutide60$64,042
MounjaroTirzepatide43$62,821
JardianceEmpagliflozin49$62,140
JanuviaSitagliptin Phosphate18$27,610
XareltoRivaroxaban17$17,648
Soliqua 100-33Insulin Glargine/Lixisenatide15$13,398
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog16$11,165
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog20$9,854
Omeprazole182$4,297
Atorvastatin Calcium292$3,263
Gabapentin114$2,982
Levothyroxine Sodium246$2,696
HumalogInsulin Lispro13$2,612

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro, Humalog$592$129,475116 claims
Novo NordiskOzempic$798$96,78373 claims
PfizerEliquis$287$73,68098 claims
Boehringer IngelheimJardiance$252$62,14049 claims
MerckJanuvia$62$27,61018 claims
Johnson & JohnsonXarelto$15$17,64817 claims
Sanofi-aventis U.S. LLCSoliqua 100-33$115$13,39815 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 928 family medicine providers in Utah.

Other family medicine in Salem

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →